(Q38156382)

29 August 2017

title

Nano-enabled delivery systems across the blood-brain barrier (English)

1 reference

29 August 2017

1 reference

1 reference

2

Kwangmeyung Kim

1 reference

29 August 2017

Seung Rim Hwang

1

1 reference

29 August 2017

publication date

30 October 2013

1 reference

Archives of Pharmacal Research

29 August 2017

published in

1 reference

29 August 2017

volume

37

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

24-30

1 reference

Transporting therapeutics across the blood-brain barrier

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Astrocyte-endothelial interactions at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The blood-brain barrier: an overview: structure, regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Blood-brain barrier transcytosis of insulin in developing rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Glutathione: new candidate neuropeptide in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Blood-brain barrier transport of therapeutics via receptor-mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Nanoparticle technology for drug delivery across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

In vivo, in vitro and in silico methods for small molecule transfer across the BBB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Emerging molecular mechanisms of brain tumour oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Why is the global CNS pharmaceutical market so under-penetrated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Biopharmaceutical drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

CNS drug delivery systems: novel approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Site-directed decapsulation of bolaamphiphilic vesicles with enzymatic cleavable surface groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Cationic vesicles from novel bolaamphiphilic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Fine structural localization of a blood-brain barrier to exogenous peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Glioblastoma cells release factors that disrupt blood-brain barrier features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Solid lipid nanoparticles for parenteral drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

Tight junctions of the blood-brain barrier: development, composition and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

21 January 2018

The blood–brain barrier

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0272-6

10.1007/S12272-013-0272-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1039305288

0 references

1 reference